Výsledky vyhledávání - "J P, Raynauld"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

OP0303 CORTICOSTEROID INJECTION IN KNEE OSTEOARTHRITIS IS ASSOCIATED WITH REDUCTION IN MENISCAL THICKNESS AND JOINT SPACE WIDTH WITH NO EFFECT ON CARTILAGE THICKNESS: A CASE CONTROL STUDY

Autor: Marc Dorais, Patrice Paiement, Johanne Martel-Pelletier, François Abram, J.-P. Pelletier, J.-P. Raynauld

Publikováno v: Annals of the Rheumatic Diseases. 79:188.1-188

Background:Intra-articular corticosteroid injections (IACI) are commonly used for the treatment of symptomatic knee osteoarthritis (OA) and therapeutic guidelines have recommended their use. However, their safety regarding the evolution of structural

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4205537e3ad53fc1c8385b6e05d7d752
https://doi.org/10.1136/annrheumdis-2020-eular.1755

Zobrazit plný text záznamu

AB0876 THE BENEFIT AND SAFETY OF DIACEREIN IN AGED AND OBESE PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS: DATA FROM THE DISSCO CLINICAL STUDY

Autor: Patrice Paiement, Johanne Martel-Pelletier, J.-P. Pelletier, J.-P. Raynauld, Marc Dorais

Publikováno v: Annals of the Rheumatic Diseases. 79:1744.1-1744

Background:The DISSCO trial (6-month international, multicentre, double-blind, randomised study on the effect of diacerein vs celecoxib in symptomatic knee osteoarthritis [OA] patients) showed that diacerein had comparable efficacy to celecoxib at re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a77f8ecf18d6851bcf05616cc4a28591
https://doi.org/10.1136/annrheumdis-2020-eular.1862

Zobrazit plný text záznamu

AB0337 TOFACITINIB MONOTHERAPY OR COMBINED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS SHOW SIMILAR RETENTION OVER FOUR YEARS. REPORT FROM RHUMADATA ®

Autor: J.-P. Pelletier, Louis Bessette, D. Sauvageau, L. Coupal, Edith Villeneuve, Isabelle Ferdinand, J.-P. Raynauld, Boulos Haraoui, Denis Choquette, Frédéric Massicotte, M.-A. Rémillard, L. Choquette Sauvageau

Publikováno v: Annals of the Rheumatic Diseases. 79:1467.1-1467

Background:Since the introduction of biologic agents around the turn of the century, the scientific evidence shows that the majority of agents, independent of the therapeutic target, have a better outcome when used in combination with methotrexate (M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7bcddd2551208258928d8bef050eb68
https://doi.org/10.1136/annrheumdis-2020-eular.2479

Zobrazit plný text záznamu

The ratio adipsin/MCP-1 is strongly associated with structural changes and CRP/MCP-1 with symptoms in obese knee osteoarthritis subjects: data from the Osteoarthritis Initiative

Autor: Johanne Martel-Pelletier, J.-P. Pelletier, Marc Dorais, J. Rousseau Trépanier, J.-P. Raynauld, François Abram, Ginette Tardif

Publikováno v: Osteoarthritis and cartilage. 27(8)

Summary Objective There is a need to identify reliable biomarkers that can predict knee osteoarthritis (OA) progression. We investigated a panel of adipokines and some related inflammatory factors alone and their ratios for their associative value at

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39b8f5407246a13dcb62805bd94dc031
https://pubmed.ncbi.nlm.nih.gov/31102776

Zobrazit plný text záznamu

OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis

Autor: Thomas M. Link, Felix Eckstein, J.-P. Pelletier, Johanne Martel-Pelletier, Frank W. Roemer, Colin G. Miller, G.E. Gold, S. Totterman, Richard Kijowski, R.E. Ochoa-Albíztegui, J.-P. Raynauld, Jeff Duryea, Roy D. Altman, Michel D. Crema, C. Peterfy, Timothy J. Mosher, David J. Hunter, Flavia M. Cicuttini, Ali Guermazi

Publikováno v: Osteoarthritis and Cartilage. 23(5):698-715

SummarySignificant advances have occurred in our understanding of the pathogenesis of knee osteoarthritis (OA) and some recent trials have demonstrated the potential for modification of the disease course. The purpose of this expert opinion, consensu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1c3102136d8991cf7255edfbb39bb7

Zobrazit plný text záznamu

FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry

Autor: M Mtibaa, E Muratti, J.-P. Pelletier, Frédéric Massicotte, J.-P. Raynauld, Roelien Postema, Boulos Haraoui, M-A Rémillard, Evo Alemao, L. Coupal, Louis Bessette, Έ. Villeneuve, D. Sauvageau, A Turcotte, Denis Choquette

Publikováno v: Poster Presentations.

Background Sustainability of treatment is important to consider when selecting a therapy for chronic conditions such as RA. Sustainability is a useful clinical marker for both long-term efficacy and safety. A recently published randomized controlled

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::daeed4a31ad2ab389bacb20acc08a961
https://doi.org/10.1136/annrheumdis-2017-eular.2326

Zobrazit plný text záznamu

Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis

Autor: J. Caron, Boulos Haraoui, J.-P. Raynauld, Denis Choquette, François Abram, J.-P. Pelletier, François Mineau, Johanne Martel-Pelletier, Marc Dorais

Publikováno v: Annals of the Rheumatic Diseases. 69:2095-2101

ObjectivesTo explore the impact of disease-modifying osteoarthritis drug (DMOAD) treatment on biomarker levels and their correlation with cartilage volume loss and disease symptoms in a 2-year phase III clinical trial in patients with knee OA.Methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e650d0e0488958a5cef67368561403
https://doi.org/10.1136/ard.2009.122002

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání